With the failure of torcetrapib, a drug that its maker hoped
would raise HDL cholesterol, people seeking to lower their heart
disease risk should rely on traditional strategies: exercise,
diet, weight control.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.